Drug Shortage Report for MED-RIVASTIGMINE
| Report ID | 263772 |
| Drug Identification Number | 02401614 |
| Brand name | MED-RIVASTIGMINE |
| Common or Proper name | Rivastigmine |
| Company Name | GENERIC MEDICAL PARTNERS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVASTIGMINE |
| Strength(s) | 1.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | Bottle of 100 Capsules |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-07-29 |
| Actual start date | 2025-07-29 |
| Estimated end date | 2025-09-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-07-30 |
| Company comments | Shortages of Rivastigmine capsules, 1.5mg, 3.0mg, 4.5mg and 6.0 mg, bottles of 100 capsules have caused a stock reduction of Med-Rivastigmine, bottles of 100. Med-Rivastigmine 1.5 mg Blister of 56 Capsules continues to be available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-07-30 | English | Compare |
| v4 | 2025-07-29 | French | Compare |
| v3 | 2025-07-29 | English | Compare |
| v2 | 2025-07-29 | English | Compare |
| v1 | 2025-07-29 | English | Compare |
Showing 1 to 5 of 5